Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion type Assertion NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_head.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion description "[Transduction of the human interleukin-2 (IL-2) gene into tumor cells was carried out in order to develop a new immunotherapy for advanced head and neck carcinomas with a poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_provenance.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion evidence source_evidence_literature NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_provenance.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion SIO_000772 10773410 NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_provenance.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion wasDerivedFrom befree-20150227 NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_provenance.
- NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_assertion wasGeneratedBy ECO_0000203 NP491994.RAlQxcHrvbYaLxwgc31ptvfCp-6TVnvWAlmoJOMHdG2qw130_provenance.